| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 570.591 | 65.015 | 20.474 | 12.174 | - | - | - | - | - | - |
| Total Income - EUR | 590.769 | 68.299 | 20.477 | 12.221 | - | - | - | - | - | - |
| Total Expenses - EUR | 583.803 | 91.247 | 52.605 | 62.755 | - | - | - | - | - | - |
| Gross Profit/Loss - EUR | 6.966 | -22.948 | -32.128 | -50.534 | - | - | - | - | - | - |
| Net Profit/Loss - EUR | 6.966 | -22.948 | -32.128 | -50.656 | - | - | - | - | - | - |
| Employees | 1 | 1 | 1 | 1 | - | - | - | - | - | - |
Check the financial reports for the company - Jason Medical S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 135 | 41 | 0 | 0 | - | - | - | - | - | - |
| Current Assets | 127.583 | 58.844 | 42.293 | 24.202 | - | - | - | - | - | - |
| Inventories | 4.952 | 5.898 | 4.835 | 2.865 | - | - | - | - | - | - |
| Receivables | 76.881 | 43.262 | 37.446 | 6.124 | - | - | - | - | - | - |
| Cash | 45.750 | 9.683 | 12 | 15.213 | - | - | - | - | - | - |
| Shareholders Funds | -49.333 | -71.778 | -102.692 | -151.464 | - | - | - | - | - | - |
| Social Capital | 40.551 | 40.138 | 39.459 | 38.735 | - | - | - | - | - | - |
| Debts | 177.050 | 130.663 | 144.985 | 175.666 | - | - | - | - | - | - |
| Income in Advance | 0 | 0 | 0 | 0 | - | - | - | - | - | - |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4646 - 4646" | |||||||||
| CAEN Financial Year |
4646
|
|||||||||
Comments - Jason Medical S.r.l.